Valuation: Tempus AI, Inc.

Market Cap 1.27TCr 1.13TCr 1.06TCr 960.59Cr 1.81TCr 1,22900Cr 1.83TCr 13TCr 4.97TCr 62TCr 4.77TCr 4.66TCr 2,00900Cr P/E 2026 *
-50.5x
P/E 2027 * -53.9x
Enterprise Value 1.33TCr 1.19TCr 1.11TCr 1.01TCr 1.89TCr 1,28700Cr 1.91TCr 13TCr 5.2TCr 65TCr 4.99TCr 4.88TCr 2,10400Cr EV / Sales 2026 *
8.33x
EV / Sales 2027 * 6.71x
Free-Float
61.4%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 01/08/2015
Director of Finance/CFO 40 01/08/2017
Chief Administrative Officer 55 01/06/2020
Director TitleAgeSince
Chairman 56 01/08/2015
Director/Board Member 53 29/10/2019
Director/Board Member 74 01/09/2017
Change 5-day change 1-year change 3-year change Capi.($)
-2.58%-12.00% - - 1.27TCr
-3.19%-3.19%+44.60%+87.98% 7.47TCr
-15.86%-16.16%+2.68%+51.09% 5.87TCr
-2.39%+0.50%+3.41%+31.33% 4.84TCr
-6.38%-8.23%+295.11%+641.81% 4.31TCr
+0.33%-0.63%+29.16%+29.84% 4.25TCr
-3.83%-2.56%-0.43%+102.31% 4.14TCr
-2.13%+1.07%+7.51%+50.31% 3.13TCr
-3.36%-5.10%-13.52%-15.92% 2.39TCr
-1.21%-7.78%-38.11%+308.57% 2.22TCr
Average -4.06%-2.63%+36.71%+143.04% 4.29TCr
Weighted average by Cap. -4.76%-1.88%+43.11%+135.38%

Financials

2026 *2027 *
Net sales 159.53Cr 142.46Cr 132.9Cr 120.72Cr 227.17Cr 15TCr 229.39Cr 1.6TCr 624.07Cr 7.85TCr 598.96Cr 585.96Cr 25TCr 196.65Cr 175.61Cr 163.82Cr 148.82Cr 280.04Cr 19TCr 282.77Cr 1.97TCr 769.3Cr 9.68TCr 738.35Cr 722.32Cr 31TCr
Net income -25Cr -22Cr -20Cr -19Cr -35Cr -2.38TCr -35Cr -245.97Cr -96Cr -1.21TCr -92Cr -90Cr -3.89TCr -24Cr -21Cr -20Cr -18Cr -34Cr -2.29TCr -34Cr -236.35Cr -92Cr -1.16TCr -89Cr -87Cr -3.74TCr
Net Debt 60Cr 53Cr 50Cr 45Cr 85Cr 5.79TCr 86Cr 598.24Cr 233.99Cr 2.94TCr 224.57Cr 219.7Cr 9.47TCr 50Cr 44Cr 41Cr 38Cr 71Cr 4.81TCr 71Cr 496.4Cr 194.16Cr 2.44TCr 186.34Cr 182.3Cr 7.86TCr
Projected Income Statement - Annual - Tempus AI, Inc.
Logo Tempus AI, Inc.
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Employees
3,800
Date Price Change
09/26/09 €61.64 -2.58%
07/26/07 €63.27 -1.91%
06/26/06 €64.50 -13.79%
05/26/05 €74.82 +10.58%
02/26/02 €67.66 -1.50%
Trader
Investor
Global
Quality
ESG MSCI
A
Ratings Surperformance© - Tempus AI, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
70.35USD
Average target price
70.61USD
Spread / Average Target
+0.37%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Tempus AI, Inc.